BMRN

BioMarin Pharmaceutical Inc.

HALAL

Score: 83/100

stock

Is BMRN Halal?

Rare-disease biopharmaceutical company — permissible medicine research; verify the debt and receivables screens against filings.

What You Should Know

BioMarin Pharmaceutical Inc. is a biotechnology company that develops and markets therapies for serious and life-threatening rare genetic diseases, including enzyme-replacement therapies, small molecules, and gene therapy. Developing and selling medicines that treat rare diseases is a permissible activity, so the business-activity screen passes. The verdict depends on the balance sheet: BioMarin has historically used convertible notes and other financing, so confirm the total-debt-to-market-cap ratio against the 33% threshold and the receivables ratio against the board's threshold using the latest filings. Interest income earned on the company's cash and investment balances should be checked against the 5% threshold and the corresponding portion of returns purified. Assuming the ratios hold, BMRN is generally screened as halal, with routine purification of minor interest income.

⚠️ Concerns

•Has historically used convertible notes and other financing — confirm total debt / market cap against the 33% threshold using the latest filings, a deciding screen
•Confirm the receivables ratio (total receivables / total assets) against the board's threshold (49–70%) using the latest filings
•Earns interest income on cash and investment balances — check it against the 5% threshold and purify the corresponding portion of returns
•Clinical, regulatory, and pricing risk make the business volatile — re-screen the ratios periodically as the balance sheet changes

🧾

Own BMRN? Purify your portfolio.

Per-holding purification amounts, zakat on your shares, and halal alternatives for flagged holdings — a personalized report prepared for you within 48 hours.

Order Your Report — $49 →

Track BMRN and 30,000+ stocks' live compliance status with Islamicly — 50% off with code ZAKAT50.Get Islamicly →